搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Chlamydia trachomatis Dihydrodipicolinate synthase (dapA) CSB-YP528240DSB
CSB-EP528240DSB
CSB-BP528240DSB
CSB-MP528240DSB
CSB-EP528240DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 3-dehydroquinate synthase (aroB) CSB-YP528241DSB
CSB-EP528241DSB
CSB-BP528241DSB
CSB-MP528241DSB
CSB-EP528241DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Arginine/agmatine antiporter (aaxC), partial CSB-YP528242DSB
CSB-EP528242DSB
CSB-BP528242DSB
CSB-MP528242DSB
CSB-EP528242DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized HIT-like protein CT_385 (CT_385) CSB-YP528243DSB
CSB-EP528243DSB
CSB-BP528243DSB
CSB-MP528243DSB
CSB-EP528243DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Ribonuclease R (rnr), partial CSB-YP528244DSB
CSB-EP528244DSB
CSB-BP528244DSB
CSB-MP528244DSB
CSB-EP528244DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Lipoprotein signal peptidase (lspA), partial CSB-YP528245DSB1
CSB-EP528245DSB1
CSB-BP528245DSB1
CSB-MP528245DSB1
CSB-EP528245DSB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Probable outer membrane protein pmpC (pmpC), partial CSB-YP528246DSB
CSB-EP528246DSB
CSB-BP528246DSB
CSB-MP528246DSB
CSB-EP528246DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 50S ribosomal protein L21 (rplU) CSB-YP528247DSB
CSB-EP528247DSB
CSB-BP528247DSB
CSB-MP528247DSB
CSB-EP528247DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Diaminopimelate epimerase (dapF) CSB-YP528248DSB
CSB-EP528248DSB
CSB-BP528248DSB
CSB-MP528248DSB
CSB-EP528248DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Phosphatidate cytidylyltransferase (cdsA), partial CSB-YP528249DSB
CSB-EP528249DSB
CSB-BP528249DSB
CSB-MP528249DSB
CSB-EP528249DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Peptide chain release factor 2 (prfB) CSB-YP528250DSB
CSB-EP528250DSB
CSB-BP528250DSB
CSB-MP528250DSB
CSB-EP528250DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Putative membrane protein insertion efficiency factor (CT_473) CSB-YP528251DSB
CSB-EP528251DSB
CSB-BP528251DSB
CSB-MP528251DSB
CSB-EP528251DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized protein CT_474 (CT_474), partial CSB-YP528252DSB1
CSB-EP528252DSB1
CSB-BP528252DSB1
CSB-MP528252DSB1
CSB-EP528252DSB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP528253DSB
CSB-EP528253DSB
CSB-BP528253DSB
CSB-MP528253DSB
CSB-EP528253DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis DNA mismatch repair protein mutL (mutL), partial CSB-YP528254DSB
CSB-EP528254DSB
CSB-BP528254DSB
CSB-MP528254DSB
CSB-EP528254DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Virulence plasmid protein pGP6-D-related protein (CT_583) CSB-YP528255DSB
CSB-EP528255DSB
CSB-BP528255DSB
CSB-MP528255DSB
CSB-EP528255DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Protein TolB (tolB) CSB-YP528256DSB
CSB-EP528256DSB
CSB-BP528256DSB
CSB-MP528256DSB
CSB-EP528256DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Folate synthesis bifunctional protein (folKP) CSB-YP528257DSB
CSB-EP528257DSB
CSB-BP528257DSB
CSB-MP528257DSB
CSB-EP528257DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis UPF0176 protein CT_627 (CT_627) CSB-YP528258DSB
CSB-EP528258DSB
CSB-BP528258DSB
CSB-MP528258DSB
CSB-EP528258DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Probable Na (+)-translocating NADH-quinone reductase subunit A CSB-YP528259DSB
CSB-EP528259DSB
CSB-BP528259DSB
CSB-MP528259DSB
CSB-EP528259DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>